Empowering Arkansas entrepreneurs in healthcare and health tech. Receive comprehensive support and networking opportunities to accelerate your venture. Apply now to join the 2024 cohort and shape the future of healthcare entrepreneurship.
Make a difference by developing technology-driven solutions to enhance healthcare infrastructure, expand access to prenatal and postnatal care, and empower women with the tools they need for better health outcomes.
Novel biomarker profile for the determination and management of metastasis to bone of patients with breast cancer.
The present invention relates novel heterocyclic analogs of combretastatin, their synthesis, and their use as anti-cancer compounds. In particular, compounds of Formula (I), Formula (II), and Formula (V) are provided.
A sound-based spirometer system including a spirometer and an electronic device having a microphone. The spirometer includes an air inlet and an air outlet. The spirometer generates a sound as an unknown amount of air passes from the air inlet to the air outlet. The sound is recordable by the microphone, and the electronic device processes the sound to determine the volume and flow rate of the unknown amount of air.
BioVentures was established as a formal outgrowth of the University of Arkansas for Medical Sciences‘ (UAMS) interest in promoting a biomedical technology industry for Arkansas and translating its research into products that benefit human health.
UAMS established BioVentures to maximize global, industrial interaction with the University of Arkansas faculty, as well as to facilitate technology transfer, the development of startup companies that are based on technology developed at UAMS, and contributions to Arkansas’ economic development.
BioVentures links the research minds at UAMS to global markets in order to advance Arkansas’ scientific and economic development.
Join us at 2 p.m. Wednesday, Oct. 16, for Health Sciences Entrepreneurship Grand Rounds, featuring Eric Peterson, Ph.D., BioVentures LLC interim president, at the Winthrop
BioVentures LLC will receive up to $2.4 million over the next four years to test prevention strategies for reducing high rates of maternal and infant
The deadline has been extended for UAMS employees to submit innovative therapeutic or drug discovery ideas to the AR Health Ventures Accelerator (ARHVA) for significant
401 South Cedar Street Little Rock, Arkansas 72205
(501) 686-6696
bioventures@uams.edu
